{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:04:20Z","timestamp":1790946260653,"version":"4.1.0"},"reference-count":43,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"abstract":"<jats:p>Wiskott-Aldrich syndrome (WAS) is a rare X-linked immunodeficiency with microthrombocytopenia, eczema, recurrent infections, autoimmune disorders, and malignancies that are life-threatening in the majority of patients. In this long-term, retrospective, multicenter study, we analyzed events that occurred in 96 WAS patients who received transplants between 1979 and 2001 who survived at least 2 years following hematopoietic stem-cell transplantation (HSCT). Events included chronic graft-versus-host disease (cGVHD), autoimmunity, infections, and sequelae of before or after HSCT complications. Three patients (3%) died 2.1 to 21 years following HSCT. Overall 7-year event-free survival rate was 75%. It was lower in recipients of mismatched related donors, also in relation with an older age at HSCT and disease severity. The most striking finding was the observation of cGVHD-independent autoimmunity in 20% of patients strongly associated with a mixed\/split chimerism status (P &lt; .001), suggesting that residual-host lymphocytes can mediate autoimmune disease despite the coexistence of donor lymphocytes. Infectious complications (6%) related to splenectomy were also significant and may warrant a more restrictive approach to performing splenectomy in WAS patients. Overall, this study provides the basis for a prospective, standardized, and more in-depth detailed analysis of chimerism and events in long-term follow-up of WAS patients who receive transplants to design better-adapted therapeutic strategies.<\/jats:p>","DOI":"10.1182\/blood-2007-03-076679","type":"journal-article","created":{"date-parts":[[2007,9,28]],"date-time":"2007-09-28T01:00:04Z","timestamp":1190941204000},"page":"439-445","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":213,"title":["Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation"],"prefix":"10.1182","volume":"111","author":[{"given":"Hulya","family":"Ozsahin","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Geneva University Hospital, Geneva, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cavazzana-Calvo","sequence":"additional","affiliation":[{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris Unit\u00e9 d'Immunologie et d'H\u00e9matologie p\u00e9diatriques and Department of Biotherapy, Department of Biostatistics, H\u00f4pital Necker-Enfants Malades, Universit\u00e9 Ren\u00e9 Descartes, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Brescia, Brescia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar","family":"Schulz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Ulm, Ulm, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian J.","family":"Thrasher","sequence":"additional","affiliation":[{"name":"Institute of Child Health, University College London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Mazzolari","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Brescia, Brescia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Slatter","sequence":"additional","affiliation":[{"name":"Newcastle General Hospital, Newcastle upon Tyne, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Le Deist","sequence":"additional","affiliation":[{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris Unit\u00e9 d'Immunologie et d'H\u00e9matologie p\u00e9diatriques and Department of Biotherapy, Department of Biostatistics, H\u00f4pital Necker-Enfants Malades, Universit\u00e9 Ren\u00e9 Descartes, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Blanche","sequence":"additional","affiliation":[{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris Unit\u00e9 d'Immunologie et d'H\u00e9matologie p\u00e9diatriques and Department of Biotherapy, Department of Biostatistics, H\u00f4pital Necker-Enfants Malades, Universit\u00e9 Ren\u00e9 Descartes, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Veys","sequence":"additional","affiliation":[{"name":"Great Ormond Street Hospital for Children, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Fasth","sequence":"additional","affiliation":[{"name":"Paediatric Immunology and Infectious Diseases Unit, Department of Pediatrics, G\u00f6teborg University, G\u00f6teborg, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert","family":"Bredius","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center, Department of Pediatrics, Leiden, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Sedlacek","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, University Hospital Motol, Charles University, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Wulffraat","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Immunology, University Medical Center, Utrecht, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ortega","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Hospital Universitario Materno-Infantil Val d'Hebron, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Heilmann","sequence":"additional","affiliation":[{"name":"Paediatric Clinic Rigshospitalet, Copenhagen, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"O'Meara","sequence":"additional","affiliation":[{"name":"Department of Haematology\/Oncology and Hematopoietic Stem Cell Transplantation (HSCT), Our Lady's Children's Hospital Crumlin, Dublin, Ireland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Wachowiak","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology and Hematopoietic Stem Cell Transplantation, University of Medical Sciences, Pozna\u0144, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Kalwak","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Medical University of Wroclaw, Wroclaw, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Matthes-Martin","sequence":"additional","affiliation":[{"name":"Children's Cancer Research Institute, St Anna Children's Hospital, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayfun","family":"Gungor","sequence":"additional","affiliation":[{"name":"University Children's Hospital, Division of Immunology, Hematology, and HSCT, Z\u00fcrich, Switzerland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aydan","family":"Ikinciogullari","sequence":"additional","affiliation":[{"name":"Ankara University, Medical School, Department of Pediatric Immunology and Allergy, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Landais","sequence":"additional","affiliation":[{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris Unit\u00e9 d'Immunologie et d'H\u00e9matologie p\u00e9diatriques and Department of Biotherapy, Department of Biostatistics, H\u00f4pital Necker-Enfants Malades, Universit\u00e9 Ren\u00e9 Descartes, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Cant","sequence":"additional","affiliation":[{"name":"Newcastle General Hospital, Newcastle upon Tyne, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Friedrich","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Ulm, Ulm, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Fischer","sequence":"additional","affiliation":[{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris Unit\u00e9 d'Immunologie et d'H\u00e9matologie p\u00e9diatriques and Department of Biotherapy, Department of Biostatistics, H\u00f4pital Necker-Enfants Malades, Universit\u00e9 Ren\u00e9 Descartes, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111823072362100_B1","first-page":"212","article-title":"Familiarer, angeborener Morbus Werlhofii?","volume":"68","author":"Wiskott","year":"1937","journal-title":"Monatsschr Kinderheilkd"},{"key":"2019111823072362100_B2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1542\/peds.13.2.133","article-title":"Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea.","volume":"13","author":"Aldrich","year":"1954","journal-title":"Pediatrics"},{"key":"2019111823072362100_B3","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-3476(05)82002-5","article-title":"A multiinstitutional survey of the Wiskott-Aldrich syndrome.","volume":"125","author":"Sullivan","year":"1994","journal-title":"J Pediatr"},{"key":"2019111823072362100_B4","first-page":"454","article-title":"The Wiskott Aldrich syndrome.","volume-title":"Primary Immune Deficiency Diseases: A Molecular and Genetic Approach","author":"Ochs","year":"2007"},{"key":"2019111823072362100_B5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0092-8674(94)90528-2","article-title":"Isolation of a novel gene mutated in Wiskott-Aldrich syndrome.","volume":"78","author":"Derry","year":"1994","journal-title":"Cell"},{"key":"2019111823072362100_B6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nri884","article-title":"WASp in immune system organization and function.","volume":"2","author":"Thrasher","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"2019111823072362100_B7","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4049\/jimmunol.161.2.1026","article-title":"Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine.","volume":"161","author":"Badolato","year":"1998","journal-title":"J Immunol"},{"key":"2019111823072362100_B8","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3259::AID-IMMU3259>3.0.CO;2-B","article-title":"Intrinsic dendritic cell abnormalities in Wiskott-Aldrich syndrome.","volume":"10","author":"Binks","year":"1998","journal-title":"Eur J Immunol"},{"key":"2019111823072362100_B9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2249.2004.02409.x","article-title":"Early deficit of lymphocytes in Wiskott-Aldrich syndrome: possible role of WASP in human lymphocyte maturation.","volume":"136","author":"Park","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"2019111823072362100_B10","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.4049\/jimmunol.151.8.4383","article-title":"T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses.","volume":"151","author":"Molina","year":"1993","journal-title":"J Immunol"},{"key":"2019111823072362100_B11","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood.V94.11.3872","article-title":"Spontaneous apoptosis in lymphocytes from patients with Wiskott-Aldrich syndrome: correlation of accelerated cell death and attenuated bcl-2 expression.","volume":"11","author":"Rawlings","year":"1999","journal-title":"Blood"},{"key":"2019111823072362100_B12","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1182\/blood.V95.4.1283.004k44_1283_1292","article-title":"Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells.","volume":"95","author":"Rengan","year":"2000","journal-title":"Blood"},{"key":"2019111823072362100_B13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s004390050162","article-title":"Wiskott-Aldrich syndrome: no strict genotype-phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product.","volume":"98","author":"Schindelhauer","year":"1996","journal-title":"Hum Genet"},{"key":"2019111823072362100_B14","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1182\/blood.V90.7.2680","article-title":"Wiskott-Aldrich syndrome\/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype.","volume":"90","author":"Zhu","year":"1997","journal-title":"Blood"},{"key":"2019111823072362100_B15","first-page":"379","article-title":"The Wiskott-Aldrich syndrome.","volume":"4","author":"Ochs","year":"2002","journal-title":"Isr Med Assoc J"},{"key":"2019111823072362100_B16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2006.02.005","article-title":"The Wiskott-Aldrich syndrome.","volume":"117","author":"Ochs","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"2019111823072362100_B17","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1182\/blood-2003-05-1592","article-title":"Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype\/genotype correlation.","volume":"104","author":"Jin","year":"2004","journal-title":"Blood"},{"key":"2019111823072362100_B18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood-2003-05-1480","article-title":"Clinical course of patients with WASP gene mutations.","volume":"103","author":"Imai","year":"2004","journal-title":"Blood"},{"key":"2019111823072362100_B19","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1542\/peds.111.5.e622","article-title":"Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients.","volume":"111","author":"Dupuis-Girod","year":"2003","journal-title":"J Pediatr"},{"key":"2019111823072362100_B20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0022-3476(05)83041-0","article-title":"Marrow transplantation from human leukocyte antigen-identical or haploidentical donors for correction of Wiskott-Aldrich syndrome.","volume":"119","author":"Brochstein","year":"1991","journal-title":"J Pediatr"},{"key":"2019111823072362100_B21","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0140-6736(68)92672-X","article-title":"Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome.","volume":"2","author":"Bach","year":"1968","journal-title":"Lancet"},{"key":"2019111823072362100_B22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0022-3476(73)80011-3","article-title":"Improved plated function following bone marrow transplantation in an infant with the Wiskott-Aldrich syndrome.","volume":"82","author":"August","year":"1973","journal-title":"J Pediatr"},{"key":"2019111823072362100_B23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00007890-197707000-00008","article-title":"Bone marrow transplantation in the Busulfan-treated rat: III. Relationship between myelosuppression and immunosuppression for conditioning bone marrow recipients.","volume":"24","author":"Tutschka","year":"1977","journal-title":"Transplantation"},{"key":"2019111823072362100_B24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJM197804272981701","article-title":"Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.","volume":"298","author":"Parkman","year":"1978","journal-title":"N Engl J Med"},{"key":"2019111823072362100_B25","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1182\/blood.V57.4.692.bloodjournal574692","article-title":"Reconstitution of normal megakaryocytopoiesis and immunologic function in Wiskott-Aldrich syndrome by marrow transplantation following myeloablation and immunosuppression with Busulfan (BU) and cyclophosphamide (CY).","volume":"57","author":"Kapoor","year":"1981","journal-title":"Blood"},{"key":"2019111823072362100_B26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1182\/blood.V61.2.341.bloodjournal612341","article-title":"Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells.","volume":"61","author":"Reisner","year":"1983","journal-title":"Blood"},{"key":"2019111823072362100_B27","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(86)90465-4","article-title":"Prevention of graft failure by an anti-LFA-1 monoclonal antibody in HLA-mismatched bone marrow transplantation.","volume":"2","author":"Fischer","year":"1986","journal-title":"Lancet"},{"key":"2019111823072362100_B28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1182\/blood.V77.2.249.249","article-title":"Reduction of graft failure by a monoclonal antibody (Anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European group for Immunodeficiency\/European Group for Bone Marrow Transplantation report.","volume":"77","author":"Fischer","year":"1991","journal-title":"Blood"},{"key":"2019111823072362100_B29","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00007890-199010000-00018","article-title":"Bone marrow transplantation for the Wiskott-Aldrich syndrome: long-term follow-up.","volume":"50","author":"Rimm","year":"1990","journal-title":"Transplantation"},{"key":"2019111823072362100_B30","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/blood.V97.6.1598","article-title":"Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program.","volume":"97","author":"Filipovich","year":"2001","journal-title":"Blood"},{"key":"2019111823072362100_B31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(03)12513-5","article-title":"Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99.","volume":"361","author":"Antoine","year":"2003","journal-title":"Lancet"},{"key":"2019111823072362100_B32","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.bmt.1705512","article-title":"Stem cell transplantation for the Wiskott-Aldrich syndrome: a single-center experience confirms efficacy of matched unrelated donor transplantation.","volume":"38","author":"Pai","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"2019111823072362100_B33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3476(96)70248-2","article-title":"Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center.","volume":"129","author":"Ozsahin","year":"1996","journal-title":"J Pediatr"},{"key":"2019111823072362100_B34","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1182\/blood.V83.4.1149.1149","article-title":"Bone Marrow Transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency.","volume":"83","author":"Fischer","year":"1994","journal-title":"Blood"},{"key":"2019111823072362100_B35","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1182\/blood.V67.2.444.444","article-title":"HLA-haploidentical bone marrow transplantation for severe combined immunodeficiency using E rosette fractionation and cyclosporin.","volume":"67","author":"Fischer","year":"1986","journal-title":"Blood"},{"key":"2019111823072362100_B36","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1182\/blood.V75.4.1031.1031","article-title":"Monoclonal antibody T-cell-depleted HLA-haploidentical bone marrow transplantation for Wiskott-Aldrich syndrome.","volume":"75","author":"Rumelhart","year":"1990","journal-title":"Blood"},{"key":"2019111823072362100_B37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimation from incomplete observation.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"2019111823072362100_B38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","article-title":"Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Part II.","volume":"35","author":"Peto","year":"1977","journal-title":"Br J Cancer"},{"key":"2019111823072362100_B39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and lifetables.","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"2019111823072362100_B40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI29539","article-title":"Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis.","volume":"117","author":"Humblet-Baron","year":"2007","journal-title":"J Clin Invest"},{"key":"2019111823072362100_B41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1084\/jem.20061334","article-title":"WASP regulates suppressor activity of human and murine CD4+CD25+Foxp3+ natural regulatory T cells.","volume":"204","author":"Marangoni","year":"2007","journal-title":"J Exp Med"},{"key":"2019111823072362100_B42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1084\/jem.20061338","article-title":"The WAS protein is required for the function of CD4+CD25+Foxp3+ regulatory T cells.","volume":"204","author":"Maillard","year":"2007","journal-title":"J Exp Med"},{"key":"2019111823072362100_B43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/hum.2006.17.303","article-title":"Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter\/cDNA-containing lentiviral vector and nonlethal irradiation.","volume":"17","author":"Dupre","year":"2006","journal-title":"Hum Gene Ther"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/1\/439\/1219779\/zh800108000439.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/1\/439\/1219779\/zh800108000439.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T07:32:18Z","timestamp":1737444738000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/111\/1\/439\/107928\/Longterm-outcome-following-hematopoietic-stemcell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2007-03-076679","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,1]]}}}